Original Article
Identification of the immune subtypes associated with the prognosis and immunotherapy of metastatic melanoma
Translational Cancer Research
2025;
14
(10)
:6136-6151
.
(31 October 2025)
Identification and validation of an immune-related programmed cell death signature for predicting prognosis and immunotherapy in large-scale multicenter cohorts for lung adenocarcinoma
Translational Cancer Research
2025;
14
(10)
:6152-6171
.
(31 October 2025)
Identification and validation of RAS signaling-related genes for prognostic prediction and immunological characterization in gastric cancer
Translational Cancer Research
2025;
14
(10)
:6172-6194
.
(31 October 2025)
The timing of surgery for elderly patients with locally advanced breast cancer
Translational Cancer Research
2025;
14
(10)
:6195-6206
.
(31 October 2025)
Cervical cancer molecular subtype identification and prognosis classification by a metabolism-related gene expression
Translational Cancer Research
2025;
14
(10)
:6207-6221
.
(31 October 2025)
Epidemiological and clinicopathologic characteristics, and prognostic factors of patients with extra-skeletal osteosarcoma: a Surveillance, Epidemiology, and End Results population study
Translational Cancer Research
2025;
14
(10)
:6222-6240
.
(31 October 2025)
Predictive factors for clinical outcome of palliative ventriculoperitoneal shunt in the treatment of leptomeningeal metastasis
Translational Cancer Research
2025;
14
(10)
:6241-6247
.
(31 October 2025)
Identification of lysine crotonylation-driven molecular clusters and immune dysregulation in HBV-related hepatocellular carcinoma via bioinformatics and machine learning
Translational Cancer Research
2025;
14
(10)
:6248-6268
.
(31 October 2025)
Transcriptomics combined with in vitro experimental validation probes polyamine metabolic profiles in low-grade gliomas
Translational Cancer Research
2025;
14
(10)
:6269-6288
.
(31 October 2025)
Ultrasound and immunohistochemical predictors of neoadjuvant chemotherapy response in breast cancer
Translational Cancer Research
2025;
14
(10)
:6289-6299
.
(31 October 2025)
Development and validation of nomograms predicting survival in operable breast cancer patients at reproductive age after breast conserving surgery and postoperative radiotherapy based on SEER database
Translational Cancer Research
2025;
14
(10)
:6300-6315
.
(31 October 2025)
Identification of cancer-associated fibroblast subpopulation and construction of an immunotherapy signature for gastric cancer
Translational Cancer Research
2025;
14
(10)
:6316-6329
.
(31 October 2025)
Integration of single-cell and bulk transcriptomics to explore prognostic and immunotherapeutic characteristics of sodium overload-induced cell death in lung adenocarcinoma
Translational Cancer Research
2025;
14
(10)
:6330-6347
.
(31 October 2025)
Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in glioma
Translational Cancer Research
2025;
14
(10)
:6348-6363
.
(31 October 2025)
Prognostic significance of key immune cell functional alterations in clear cell renal cell carcinoma
Translational Cancer Research
2025;
14
(10)
:6364-6387
.
(31 October 2025)
Comparative microbiome profiling reveals unique signatures in multiple primary lung cancers
Translational Cancer Research
2025;
14
(10)
:6388-6402
.
(31 October 2025)
PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinoma: a retrospective cohort study
Translational Cancer Research
2025;
14
(10)
:6403-6413
.
(31 October 2025)
CCT4 as a prognostic biomarker correlated with immune infiltration and hepatocyte dedifferentiation in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(10)
:6414-6428
.
(31 October 2025)
Anti-ovarian cancer effects of forsythiaside A: insights from in vitro and in vivo studies
Translational Cancer Research
2025;
14
(10)
:6429-6441
.
(31 October 2025)
A pentacyclic triterpene tormentic acid inhibits the proliferation and migration of pancreatic ductal adenocarcinoma cells
Translational Cancer Research
2025;
14
(10)
:6442-6453
.
(31 October 2025)
shRNA-based PD-1 suppression preserves memory phenotype and function of CD19-targeted CAR-T cell
Translational Cancer Research
2025;
14
(10)
:6454-6468
.
(31 October 2025)
Unveiling PIK3CA mutation: a prognostic beacon in endometrial carcinoma and its immune implications
Translational Cancer Research
2025;
14
(10)
:6469-6482
.
(31 October 2025)
Methylation-regulated tumor suppressor gene HOXB4 inhibits human lung adenocarcinoma A549 cell invasion and metastasis through the RAP1 signaling pathway
Translational Cancer Research
2025;
14
(10)
:6483-6496
.
(31 October 2025)
The role of cancer stem cells in the progression of colorectal cancer and the tumor microenvironment: new perspectives from single-cell RNA sequencing and spatial transcriptomics analyses
Translational Cancer Research
2025;
14
(10)
:6497-6519
.
(31 October 2025)
KRT23 promotes proliferation invasion and metastasis of gastric cancer through epithelial-mesenchymal transition mediated by the PI3K/AKT/mTOR signaling pathway
Translational Cancer Research
2025;
14
(10)
:6520-6535
.
(31 October 2025)
B7 homolog 6 promotes the killing activity of natural killer cells against cervical cancer through the downstream ERK pathway of NKp30
Translational Cancer Research
2025;
14
(10)
:6536-6550
.
(31 October 2025)
LINC01314 suppresses proliferation and invasion via epithelial-to-mesenchymal transition regulation in lung adenocarcinoma
Translational Cancer Research
2025;
14
(10)
:6551-6564
.
(31 October 2025)
Development and validation of a prognostic prediction model for gastric cancer based on lipophagy-related genes
Translational Cancer Research
2025;
14
(10)
:6565-6587
.
(31 October 2025)
Bioinformatics analysis identifies ULK3 as a novel prognostic and immune-related biomarker in esophageal cancer
Translational Cancer Research
2025;
14
(10)
:6588-6604
.
(31 October 2025)
Development and validation of a nomogram comprising GLUT1 and clinical characteristics for predicting overall survival in intrahepatic cholangiocarcinoma
Translational Cancer Research
2025;
14
(10)
:6605-6617
.
(31 October 2025)
Integrative analysis of the potential of DISP3 as a biomarker for thyroid cancer
Translational Cancer Research
2025;
14
(10)
:6618-6636
.
(31 October 2025)
Liriopesides B inhibits proliferation and metastasis and induces apoptosis of oral squamous cell carcinoma via the PI3K/Akt/mTOR signaling pathway
Translational Cancer Research
2025;
14
(10)
:6637-6652
.
(31 October 2025)
Intratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis
Translational Cancer Research
2025;
14
(10)
:6653-6666
.
(31 October 2025)
TIPE3 promotes breast cancer progression and metastasis via the AKT-GSK3β-β-catenin/Snail pathway
Translational Cancer Research
2025;
14
(10)
:6667-6680
.
(31 October 2025)
Multi-omics analysis reveals intratumoral microbiota as modulators of the immune environment within thyroid cancer
Translational Cancer Research
2025;
14
(10)
:6681-6693
.
(31 October 2025)
Prognostic prediction nomogram of elderly patients with metastasis colon cancer and distant metastasis pattern: a SEER database analysis
Translational Cancer Research
2025;
14
(10)
:6694-6708
.
(31 October 2025)
Machine learning models for predicting survival in patients of hepatocellular carcinoma with second primary malignancy
Translational Cancer Research
2025;
14
(10)
:6709-6722
.
(31 October 2025)
Integrative analysis identified THBS1 as a key prognostic biomarker with therapeutic vulnerability in patients with laryngeal cancer
Translational Cancer Research
2025;
14
(10)
:6723-6737
.
(31 October 2025)
Construction and verification of a prognostic model for cervical cancer based on genes associated with the p53 regulatory pathway
Translational Cancer Research
2025;
14
(10)
:6738-6757
.
(31 October 2025)
Unveiling critical genes and molecular subtypes in ovarian cancer: insights into tumor immunity and carbohydrate-lipid metabolism
Translational Cancer Research
2025;
14
(10)
:6758-6770
.
(31 October 2025)
Integrated multi-omic analysis unravels the characteristics of the metabolism-related intratumoral microbes and establishes a novel signature for predicting prognosis and therapeutic response in lung adenocarcinoma
Translational Cancer Research
2025;
14
(10)
:6771-6790
.
(31 October 2025)
Decoding the genomic landscape of adenoid cystic carcinoma: a retrospective cohort study of MYB family alterations, NOTCH pathway activation, and clinical outcomes
Translational Cancer Research
2025;
14
(10)
:6791-6802
.
(31 October 2025)
Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene
Translational Cancer Research
2025;
14
(10)
:6803-6813
.
(31 October 2025)
Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma
Translational Cancer Research
2025;
14
(10)
:6814-6833
.
(31 October 2025)
CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer
Translational Cancer Research
2025;
14
(10)
:6834-6848
.
(31 October 2025)
Identification of PDGFRB as a prognostic immune-related biomarker in gastric cancer through bioinformatics and clinical analysis
Translational Cancer Research
2025;
14
(10)
:6849-6863
.
(31 October 2025)
NSD2 mediates NF-κB and matrix metalloproteinases to drive hepatocellular carcinoma malignant progression
Translational Cancer Research
2025;
14
(10)
:6864-6880
.
(31 October 2025)
Molecular dynamics simulation and single-cell and spatial transcriptomics validate immune and prognostic biomarkers in colorectal cancer and construct a clinical prognostic model
Translational Cancer Research
2025;
14
(10)
:6881-6906
.
(31 October 2025)
Study of non-surgical therapeutic patterns and prognosis in elderly patients with stage II non-small-cell lung cancer: an investigational study based on the SEER database
Translational Cancer Research
2025;
14
(10)
:6907-6918
.
(31 October 2025)
TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation
Translational Cancer Research
2025;
14
(10)
:6919-6939
.
(31 October 2025)
Identification of prognostic genes associated with sphingosine-1-phosphate in gastric cancer to construct a risk mode
Translational Cancer Research
2025;
14
(10)
:6940-6959
.
(31 October 2025)
Development and verification of risk prediction nomograms for overall and specific mortality in primary small bowel cancer: a population-based study
Translational Cancer Research
2025;
14
(10)
:6960-6974
.
(31 October 2025)
ATP citrate lyase (ACLY) promotes the occurrence of gastric cancer through regulating lipid metabolism
Translational Cancer Research
2025;
14
(10)
:6975-6989
.
(31 October 2025)
Development and validation of a machine learning-based prognostic model using mitochondrial dysfunction-related genes for colorectal cancer patients
Translational Cancer Research
2025;
14
(10)
:6990-7006
.
(31 October 2025)
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography metabolic parameters combined with serum apolipoprotein A1 in patients with diffuse large B-cell lymphoma: a clinical study
Translational Cancer Research
2025;
14
(10)
:7007-7017
.
(31 October 2025)
A novel prognostic tool for triple-negative breast cancer: creating and testing a parthanatos-related gene model
Translational Cancer Research
2025;
14
(10)
:7018-7036
.
(31 October 2025)
Development and validation of a machine learning model for predicting 3-year overall survival in metastatic nasopharyngeal carcinoma: a SEER database and web visualization study
Translational Cancer Research
2025;
14
(10)
:7037-7052
.
(31 October 2025)
A novel disulfidptosis-related lncRNAs index to predict prognosis and therapeutic target in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(10)
:7053-7070
.
(31 October 2025)
Constructing an immune-related prognostic model and exploring the function of HMGB3, TNFSF4, and CORO2A in breast cancer
Translational Cancer Research
2025;
14
(10)
:7071-7088
.
(31 October 2025)
Single-cell analysis of tumor microenvironment immune homeostasis and identification of prognostic biomarkers in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(10)
:7089-7101
.
(31 October 2025)
Efficacy, safety and cost-effectiveness of chemo-immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: an updated systematic review and cost-effectiveness analysis
Translational Cancer Research
2025;
14
(10)
:7102-7118
.
(31 October 2025)
Integrative single-cell and bulk transcriptomes analyses reveal T cell-related prognostic risk model and tumor immune microenvironment modulation in colorectal cancer
Translational Cancer Research
2025;
14
(10)
:7119-7135
.
(31 October 2025)
Identification of molecular subtypes for breast cancer based on butyrate metabolism-related genes to assess prognosis and immune landscape
Translational Cancer Research
2025;
14
(10)
:7136-7156
.
(31 October 2025)
RNA sequencing and bioinformatics analysis have identified MAST1 as a potential biomarker and therapeutic target for cervical cancer
Translational Cancer Research
2025;
14
(10)
:7157-7169
.
(31 October 2025)
Clinical significance of CD155 expression and correlation with immune cell infiltration in triple-negative breast cancer
Translational Cancer Research
2025;
14
(10)
:7170-7185
.
(31 October 2025)
Epidemiological characteristics and prognostic factors of high-grade brainstem glioma for all ages and the establishment of a nomogram
Translational Cancer Research
2025;
14
(10)
:7186-7198
.
(31 October 2025)
A deep learning-based prognostic prediction model for distal cholangiocarcinoma incorporating the metabolism-inflammation marker monocyte-to-high-density lipoprotein cholesterol ratio
Translational Cancer Research
2025;
14
(10)
:7199-7213
.
(31 October 2025)
Exploration of efferocytosis-related genes as potential therapeutic targets in endometrial cancer
Translational Cancer Research
2025;
14
(10)
:7214-7228
.
(31 October 2025)
FBXO5 drives hepatocellular carcinoma progression and is a target for tea polyphenol-mediated inhibition
Translational Cancer Research
2025;
14
(10)
:7229-7244
.
(31 October 2025)
Ferroptosis-associated RNA-binding proteins predict clinical outcomes in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(10)
:7245-7255
.
(31 October 2025)
Deciphering immune landscapes: an ICD-lncRNA-derived prognostic signature for pancreatic adenocarcinoma
Translational Cancer Research
2025;
14
(10)
:7256-7276
.
(31 October 2025)
Immune-related long noncoding RNAs in predicting the prognosis and immune landscape of intrahepatic cholangiocarcinoma: a bioinformatics analysis with experimental verification
Translational Cancer Research
2025;
14
(10)
:7277-7290
.
(31 October 2025)
The role of liquid-liquid phase separation in hepatocellular carcinoma: single-cell analysis and identification of prognostic biomarkers
Translational Cancer Research
2025;
14
(10)
:7291-7310
.
(31 October 2025)
A novel manganese metabolism- and immune-related prognostic risk model for acute myeloid leukemia
Translational Cancer Research
2025;
14
(10)
:7311-7328
.
(31 October 2025)
Radiomics-based machine learning for glioma grade classification: a multicenter study with SHapley Additive exPlanations interpretability analysis
Translational Cancer Research
2025;
14
(10)
:7329-7346
.
(31 October 2025)
The systemic immune-inflammation index in the efficacy prediction of neoadjuvant chemotherapy in patients with endometrial cancer
Translational Cancer Research
2025;
14
(10)
:7347-7357
.
(31 October 2025)
CXCR3 enhanced murine chimeric antigen receptor T cells in the treatment of solid tumors
Translational Cancer Research
2025;
14
(10)
:7358-7373
.
(31 October 2025)
A diagnostic test evaluation: dynamic optical functional imaging system for early-stage breast cancer detection
Translational Cancer Research
2025;
14
(10)
:7374-7386
.
(31 October 2025)
Bulk and single-cell transcriptomics of stomach adenocarcinoma provide prognostic insights via the application of a novel gene signature associated with manganese metabolism
Translational Cancer Research
2025;
14
(10)
:7387-7399
.
(31 October 2025)
CST7+ macrophages/monocytes in melanoma: single-cell insights into immunotherapy response
Translational Cancer Research
2025;
14
(10)
:7400-7418
.
(31 October 2025)
The association of geriatric nutritional risk and perioperative anesthesia–related adverse reactions in elderly patients with colorectal cancer—a prospective study
Translational Cancer Research
2025;
14
(10)
:7419-7427
.
(31 October 2025)
Review Article
Advances and challenges in circulating tumor DNA-based early detection of lung cancer
Translational Cancer Research
2025;
14
(10)
:7428-7437
.
(31 October 2025)
A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy
Translational Cancer Research
2025;
14
(10)
:7438-7449
.
(31 October 2025)
Case Report: iMDT Corner
Long-term partial response after camrelizumab plus chemotherapy induction therapy and camrelizumab maintenance therapy beyond two years in squamous non-small cell lung cancer: a case report
Translational Cancer Research
2025;
14
(10)
:7450-7456
.
(31 October 2025)
Erratum
Erratum: Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver
Translational Cancer Research
2025;
14
(10)
:7457
.
(31 October 2025)
Erratum: LncRNA HEIH modulates the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-193a-5p/CDK8 axis
Translational Cancer Research
2025;
14
(10)
:7458-7462
.
(31 October 2025)
